Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1972 1
1975 4
1976 1
1977 3
1978 4
1979 2
1980 2
1981 6
1982 11
1983 6
1984 9
1985 16
1986 5
1987 10
1988 20
1989 33
1990 29
1991 59
1992 63
1993 83
1994 86
1995 66
1996 104
1997 87
1998 104
1999 95
2000 115
2001 87
2002 139
2003 146
2004 136
2005 149
2006 164
2007 169
2008 184
2009 212
2010 215
2011 226
2012 239
2013 265
2014 310
2015 311
2016 317
2017 321
2018 300
2019 319
2020 310
2021 300
2022 251
2023 225
2024 86

Text availability

Article attribute

Article type

Publication date

Search Results

5,628 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Increased risk of malignant lymphoma"
Page 1
Epidemiology of Follicular Lymphoma.
Cerhan JR. Cerhan JR. Hematol Oncol Clin North Am. 2020 Aug;34(4):631-646. doi: 10.1016/j.hoc.2020.02.001. Epub 2020 May 5. Hematol Oncol Clin North Am. 2020. PMID: 32586570 Free PMC article. Review.
Follicular lymphoma (FL) is a common indolent lymphoma subtype in Western countries. ...Identification of risk factors for FL requires further research....
Follicular lymphoma (FL) is a common indolent lymphoma subtype in Western countries. ...Identification of risk factors …
A predictive model for aggressive non-Hodgkin's lymphoma.
International Non-Hodgkin's Lymphoma Prognostic Factors Project. International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med. 1993 Sep 30;329(14):987-94. doi: 10.1056/NEJM199309303291402. N Engl J Med. 1993. PMID: 8141877 Free article. Clinical Trial.
The Ann Arbor classification, used to determine the stage of this disease, does not consistently distinguish between patients with different long-term prognoses. This project was undertaken to develop a model for predicting outcome in patients with aggressive non-Ho …
The Ann Arbor classification, used to determine the stage of this disease, does not consistently distinguish between patients with different …
Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups.
Batlevi CL, Sha F, Alperovich A, Ni A, Smith K, Ying Z, Soumerai JD, Caron PC, Falchi L, Hamilton A, Hamlin PA, Horwitz SM, Joffe E, Kumar A, Matasar MJ, Moskowitz AJ, Moskowitz CH, Noy A, Owens C, Palomba LM, Straus D, von Keudell G, Zelenetz AD, Seshan VE, Younes A. Batlevi CL, et al. Blood Cancer J. 2020 Jul 17;10(7):74. doi: 10.1038/s41408-020-00340-z. Blood Cancer J. 2020. PMID: 32678074 Free PMC article.
Patients with follicular lymphoma (FL) frequently require multiple treatments during their disease course; however, survival based on lines of treatment remains poorly described in the post-rituximab era. Also, the Follicular Lymphoma International Prognos
Patients with follicular lymphoma (FL) frequently require multiple treatments during their disease course; however, survival b …
Burden of lymphoma in China, 1990-2019: an analysis of the global burden of diseases, injuries, and risk factors study 2019.
Liu W, Liu J, Song Y, Wang X, Mi L, Cai C, Zhao D, Wang L, Ma J, Zhu J. Liu W, et al. Aging (Albany NY). 2022 Apr 10;14(7):3175-3190. doi: 10.18632/aging.204006. Epub 2022 Apr 10. Aging (Albany NY). 2022. PMID: 35398840 Free PMC article.
Moreover, disparities in lymphoma burden were observed across the provinces. Between 1990 and 2019, the disability-adjusted life year number decreased by 57.8% for Hodgkin lymphoma, and increased by 100.9% for non-Hodgkin lymphoma. CONCLUSION: Burden o …
Moreover, disparities in lymphoma burden were observed across the provinces. Between 1990 and 2019, the disability-adjusted life year …
Hodgkin lymphoma.
Gobbi PG, Ferreri AJ, Ponzoni M, Levis A. Gobbi PG, et al. Crit Rev Oncol Hematol. 2013 Feb;85(2):216-37. doi: 10.1016/j.critrevonc.2012.07.002. Epub 2012 Aug 4. Crit Rev Oncol Hematol. 2013. PMID: 22867814 Review.
Mortality from HL has been progressively decreasing, as confirmed by the most recent 5-year survival figure of 81%. The list of putative prognostic factors in HL has been increasing, but most factors still require prospective validation. ...Although some evidence su …
Mortality from HL has been progressively decreasing, as confirmed by the most recent 5-year survival figure of 81%. The list of putative …
Systemic lupus erythematosus and lymphoma: Incidence, pathogenesis and biology.
Klein A, Polliack A, Gafter-Gvili A. Klein A, et al. Leuk Res. 2018 Dec;75:45-49. doi: 10.1016/j.leukres.2018.11.004. Epub 2018 Nov 12. Leuk Res. 2018. PMID: 30458319 Review.
Systemic Lupus Erythematosus (SLE), a well recognized systemic autoimmune disease is associated with an increased risk of malignancies, particularly lymphoma. Various studies have shown this risk to be as high as 4-7-fold compared to the general …
Systemic Lupus Erythematosus (SLE), a well recognized systemic autoimmune disease is associated with an increased risk of
Serum levels of polychlorinated biphenyls and risk of non-Hodgkin lymphoma: A hospital-based case-control study.
Magoni M, Donato F, Apostoli P, Rossi G, Comba P, Fazzo L, Speziani F, Leonardi L, Orizio G, Scarcella C, Anastasia A, Tucci A; Brescia NHL-PCB Working Group. Magoni M, et al. Chemosphere. 2019 Nov;235:969-975. doi: 10.1016/j.chemosphere.2019.06.193. Epub 2019 Jul 1. Chemosphere. 2019. PMID: 31561313 Review.
Polychlorinated biphenyls (PCB) have been classified by the International Agency for Research on Cancer (IARC) in Group 1 as carcinogenic to human, based on sufficient evidence in humans of an increased risk of cutaneous malignant melanoma and limited …
Polychlorinated biphenyls (PCB) have been classified by the International Agency for Research on Cancer (IARC) in Group 1 as carcinogenic to …
Clinical Characteristics and Management of Patients With Concomitant Liver Cirrhosis and Lymphoma: A Systematic Review.
Jelicic J, Larsen TS, Fialla AD, Bukumiric Z, Andjelic B. Jelicic J, et al. Clin Lymphoma Myeloma Leuk. 2022 Nov;22(11):e981-e991. doi: 10.1016/j.clml.2022.07.006. Epub 2022 Jul 17. Clin Lymphoma Myeloma Leuk. 2022. PMID: 35948478 Review.
Over the years, a rising incidence of liver cirrhosis and lymphoma has been observed. Therefore, the risk of having cirrhosis as a comorbidity increases, thus challenging treatment approaches as data on the management of these patients is lacking. ...M …
Over the years, a rising incidence of liver cirrhosis and lymphoma has been observed. Therefore, the risk of having cir …
Increased risk of second lung cancer in Hodgkin's lymphoma survivors: a meta-analysis.
Ibrahim EM, Kazkaz GA, Abouelkhair KM, Al-Mansour MM, Al-Fayea TM, Al-Foheidi M, Bayer AM, Elmasri OA. Ibrahim EM, et al. Lung. 2013 Feb;191(1):117-34. doi: 10.1007/s00408-012-9418-4. Epub 2012 Oct 6. Lung. 2013. PMID: 23053567 Review.
BACKGROUND: Patients treated for Hodgkin's lymphoma (HL) have a higher risk of developing second lung cancer (SLC) compared with the general population. ...RR increased by increasing duration of follow-up, reaching the highest value at 10-14 yea …
BACKGROUND: Patients treated for Hodgkin's lymphoma (HL) have a higher risk of developing second lung cancer (SLC) comp …
The bidirectional increased risk of B-cell lymphoma and T-cell lymphoma.
Chihara D, Dores GM, Flowers CR, Morton LM. Chihara D, et al. Blood. 2021 Sep 2;138(9):785-789. doi: 10.1182/blood.2020010497. Blood. 2021. PMID: 33822002 Free PMC article.
Lymphoma survivors have a significantly higher risk of developing second primary lymphoma than the general population; however, bidirectional risks of developing B- and T-cell lymphomas (BCLs and TCLs) specifically are less well understood. ...We obser
Lymphoma survivors have a significantly higher risk of developing second primary lymphoma than the general popul
5,628 results